AaviGen GmbH

https://www.aavigen.com

AaviGen was founded in 2019 on the understanding that successful gene therapy requires optimized delivery of therapeutic targets to the diseased heart. AaviGen’s scientific approach is documented in numerous peer-reviewed scientific publications and validated by its founders’ track record in scientific innovations for the diagnosis and treatment of cardiac diseases, including gene therapy medicinal products. *

	Start	2019-05-22 established (s-off)
	Predecessor	University of Heidelberg (Ruperto Carola)
	Industry	gene therapy
	Industry 2	adeno-associated viral vector (AAV vector)
	Person	Most, Patrick (Aavigen 201905– Managing Director + Inocard 201401– Managing Director + Co-founder)
	Person 2	Lerchenmüller, Marc (AaviGen 202307 Managing Director + CFO + Co-Founder)

	Region	Heidelberg
	Country	Germany
	Street	410 Im Neuenheimer Feld
	City	69120 Heidelberg
	Tel	+49- 6221-56-8900
		Address record changed: 2023-08-24

Basic data	Employees	n. a.

		* Document for »About Section«: AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg.

		Record changed: 2024-06-07

Picture biomindz TRON LSG Mainz Translation Cancer Immunotherapy 650x200px

More documents for AaviGen GmbH

[1] AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)